Concentrix Corporation $CNXC Shares Sold by Pzena Investment Management LLC

Pzena Investment Management LLC lessened its stake in shares of Concentrix Corporation (NASDAQ:CNXC) by 2.8% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,212,592 shares of the company’s stock after selling 64,188 shares during the quarter. Pzena Investment Management LLC’s holdings in Concentrix were worth $102,111,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also made changes to their positions in the stock. Quent Capital LLC acquired a new position in shares of Concentrix in the 3rd quarter worth approximately $29,000. Geneos Wealth Management Inc. raised its position in Concentrix by 532.7% in the first quarter. Geneos Wealth Management Inc. now owns 620 shares of the company’s stock valued at $34,000 after purchasing an additional 522 shares during the period. Rothschild Investment LLC lifted its stake in Concentrix by 14,980.0% during the third quarter. Rothschild Investment LLC now owns 754 shares of the company’s stock worth $35,000 after purchasing an additional 749 shares in the last quarter. IFP Advisors Inc boosted its position in shares of Concentrix by 473.8% during the second quarter. IFP Advisors Inc now owns 700 shares of the company’s stock worth $37,000 after buying an additional 578 shares during the period. Finally, True Wealth Design LLC boosted its position in shares of Concentrix by 39.3% during the second quarter. True Wealth Design LLC now owns 1,163 shares of the company’s stock worth $61,000 after buying an additional 328 shares during the period. 90.34% of the stock is owned by hedge funds and other institutional investors.

Concentrix Price Performance

Shares of NASDAQ CNXC opened at $33.13 on Thursday. The company has a debt-to-equity ratio of 1.67, a current ratio of 1.40 and a quick ratio of 1.40. The company has a market cap of $2.03 billion, a price-to-earnings ratio of -1.59, a price-to-earnings-growth ratio of 0.33 and a beta of 0.50. The stock’s 50-day moving average is $39.77 and its two-hundred day moving average is $43.32. Concentrix Corporation has a 1-year low of $29.35 and a 1-year high of $66.00.

Concentrix (NASDAQ:CNXC) last announced its quarterly earnings data on Tuesday, January 13th. The company reported $2.95 EPS for the quarter, topping analysts’ consensus estimates of $2.93 by $0.02. Concentrix had a positive return on equity of 16.91% and a negative net margin of 13.02%.The business had revenue of $2.55 billion during the quarter, compared to the consensus estimate of $2.54 billion. During the same period in the previous year, the company posted $3.26 earnings per share. The business’s revenue for the quarter was up 4.3% on a year-over-year basis. Concentrix has set its Q1 2026 guidance at 2.570-2.690 EPS and its FY 2026 guidance at 11.480-12.070 EPS. Analysts forecast that Concentrix Corporation will post 10.11 EPS for the current fiscal year.

Concentrix Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, February 10th. Shareholders of record on Friday, January 30th were given a $0.36 dividend. The ex-dividend date of this dividend was Friday, January 30th. This represents a $1.44 dividend on an annualized basis and a dividend yield of 4.3%. Concentrix’s dividend payout ratio is currently -6.91%.

Insider Buying and Selling at Concentrix

In other Concentrix news, CEO Christopher A. Caldwell bought 1,000 shares of the company’s stock in a transaction that occurred on Thursday, January 29th. The shares were purchased at an average price of $37.07 per share, with a total value of $37,070.00. Following the completion of the acquisition, the chief executive officer directly owned 362,075 shares of the company’s stock, valued at $13,422,120.25. This represents a 0.28% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 3.20% of the company’s stock.

Analyst Ratings Changes

Several equities analysts recently issued reports on the company. Robert W. Baird set a $52.00 target price on Concentrix in a research note on Wednesday, January 14th. Weiss Ratings cut shares of Concentrix from a “hold (c-)” rating to a “sell (d)” rating in a research report on Thursday, January 29th. Wall Street Zen raised shares of Concentrix from a “hold” rating to a “buy” rating in a research note on Saturday, February 14th. Finally, Barrington Research restated an “outperform” rating and issued a $62.00 price objective on shares of Concentrix in a report on Monday, January 12th. Three research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $63.75.

About Concentrix

Concentrix Inc (NASDAQ: CNXC) is a global business services company specializing in customer engagement solutions and technology‐driven business process outsourcing. The firm’s offerings encompass customer care delivered across voice and digital channels, back‐office processing, analytics and consulting, and automated workflow management. By integrating proprietary platforms, strategic partnerships and advanced automation, Concentrix helps clients enhance customer experiences and streamline operations.

Its capabilities extend to digital marketing and technology implementation, leveraging artificial intelligence, machine learning and data analytics to optimize customer journeys.